Healthy volunteer study of CSF fluid and oral bioavailability of RR-HNK
Ended Awarded Last action
- Contract number
- 75N95021F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $405,770
Award facts
- Opportunity
-
- 75N95021R00058 Solicitation number
- Contract value 100% obligated
- $405,769.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27708, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$83,795 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $489,565 |
About this award
The National Institute on Drug Abuse issued a delivery order to Duke University on September 30, 2021, under the Phase I Clinical Trials for Development of Neurotherapeutics parent IDIQ, with a ceiling value of $405,769.61 and cost-no-fee pricing.
The order funds a healthy volunteer study of cerebrospinal fluid and oral bioavailability of RR-HNK in support of neurotherapeutics development. Place of performance is Durham, NC. The ultimate completion date is May 31, 2024.
Service Contract Inventory reporting reflects actual government-invoiced labor across three fiscal years: FY2022 yielded $19 thousand invoiced at 0.1 FTEs and 184 contractor hours ($101.17 per hour); FY2023 saw $387 thousand invoiced at 0.4 FTEs and 913 contractor hours ($424.25 per hour); FY2024 recorded $34 thousand invoiced at 0.1 FTEs and 235 contractor hours ($144.29 per hour). Duke University self-performed all reported hours with no subcontractors engaged.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to Duke University by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $405,770 on 75N95021F00001.
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under HHSN271201600004I, an indefinite delivery contract, on Phase I Clinical Trials for Development of Neurotherapeutics.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award